China's pharmaceutical market
Webority industry as a part of its 13th Five-Year Plan and the Made in China 2025 initiative. The development of China’s pharma-ceutical industry follows a pattern seen in some of its other industries, such as chemicals and telecommunications, where state support promotes domestic companies at the expense of foreign competitors. WebReport Overview. The global pharmacy market size was valued at USD 1,008.5 billion in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2028. The increasing number of people suffering from diseases, increasing aging population, and growing number of prescriptions are the key parameter driving the market.
China's pharmaceutical market
Did you know?
WebData shows that in 2024, the operating revenue of China's pharmaceutical industry reached RMB 2,928.85 billion. It is expected that in 2024, the revenue of China's … http://www.china.org.cn/business/2024-12/20/content_75532721.htm
WebDec 20, 2024 · According to data issued by industry research website chinabaogao.com, in 2024, the terminal market volume of China's pharmaceutical market reached 1.7 … WebMar 4, 2024 · Major companies in the pharmaceuticals market include Johnson & Johnson, Novartis AG, Bristol-Myers Squibb, AbbVie, Sanofi S. A, Pfizer Inc. , GlaxosmithKline, F. Hoffmann-La Roche Ltd. , Merck ...
WebNov 10, 2024 · China’s healthcare market is predicted to expand from around US$900 billion (RMB 6.47 trillion) in 2024 to US$2.3 trillion (RMB 16.53 trillion) in 2030, and its market size is second to only the US. China’s total expenditure on healthcare as a component of its GDP increased to 5.35 percent in 2024 from 4.23 percent in 2010.. … WebAug 14, 2024 · Largest Chinese pharmaceutical companies 2024, by sales value. According to the annual ranking of Forbes Global 2000 which measures the world's …
WebAug 14, 2024 · In addition, when highlighting our dependence on Chinese-made pharmaceuticals, we could overlook the other side of the coin: China needs finished drugs made in the United States. China is facing a ...
WebReport Overview. The global pharmacy market size was valued at USD 1,008.5 billion in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 4.3% … inci name for annatto seed powderWebDec 20, 2024 · According to data issued by industry research website chinabaogao.com, in 2024, the terminal market volume of China's pharmaceutical market reached 1.7 trillion yuan ($242.9 billion), 6.3 … inci name for blood orange essential oilWebMar 5, 2024 · Since 2010, FDA leadership has stated that 40% of finished medications and 80% of the active pharmaceutical ingredients (APIs) used to make all finished … inbestigative report druh rehabWebAsia-Pacific Pharmaceutical Industry Outlook, 2024 Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2024 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. inci name for bentonite clayWebAug 15, 2024 · Total operating revenue of China's pharmaceutical industry 2013-2024. Total operating revenue of the pharmaceutical industry in China from 2013 to 2024 (in … inci name for cedarwood oilWebApr 27, 2024 · China’s dominance in pharmaceutical raw materials and the shift of production of key generic drugs to India, which now supplies 40% of generics to the world market, are front-burner issues for ... inci name for ceto stearyl alcoholWebChina’s Pharmaceutical Market Size. In 2024, the market size of pharmaceutical and health products in China reached 220 billion USD, while 29.4% of these products were supplied by imports. By 2024, … inci name for bilberry extract